5 Reasons to attend (online):

1) Understand how medical affairs are at the forefront of new pharmaceutical industry commercial models and what capabilities will maximise effectiveness

2) Find out what global and local departmental structures and processes enable medical affairs to add value to internal and external stakeholders

3) Appreciate the disruptive emergence of digital medical affairs and how to take advantage of novel, hybrid capabilities now, and in the future

4. Learn how to measure success in both quantitative and qualitative terms, especially in terms of ‘share of voice.’

5. Learn from real-life experiences from thought leaders who developed next generation capabilities and enhanced effectiveness

 

 

Speakers List

INDUSTRY EXPERTS

Franchise Head, US Oncology Medical Affairs
AstraZeneca

Executive Director, Ex-US Medical Capabilities
Amgen

Vice President, North America Medical Affairs Hospital Business
Pfizer

Head of Medical Affairs Oncology Region Europe
Novartis

Vice President Market Access
Medtronic

Senior Director Clinical/Medical Affairs
Medtronic

Regional Director, Medical Science Liaisons
Novartis, USA

Medical Education and Digital Manager
Novartis

Field Director, Medical Science Liaisons
Astellas

 

 

Senior Director, Global Medical Science Liaison
Philips Healthcare

Director of Global Data Generation
Ionis Pharmaceuticals 

 

EXPERIENCED SOLUTION PROVIDERS

Global Head, Medscape Medical Affairs
Medscape Medical Affairs

Senior Vice President, Learning & Development
OPEN Health Medical Communications

Event Structure

Event Overview

DEVELOPING MEDAFFAIRS STRATEGIC CAPABILITIES

Day 1 - 20th July, 2021

CAPABILITIES TO ENGAGE & ADD-VALUE TO KOLS & STAKEHOLDERS

Day 2 - 21st July, 2021

Event Partner

Related Videos

Presentation

Informing oncology strategies through insights and engagement

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE

Innovation in an already crowded oncology space has created a challenge for medical affairs.  The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the  scientific need of experts, while continuously demonstrating value.  To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to  leverage this information to inform targeted decisions and investments. 

Speaker

Robert Groebel

Vice President - Global Medical Strategy
Monocl

Presentation

Omnichannel in Medical Affairs - an evidence-based approach to personalising healthcare communications

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • So what does omnichannel actually mean for Medical Affairs?
  • Examples of evidence and data-based healthcare communications
  • Right message, right place, right audience
Speaker

James Turnbull

Senior Vice President, Omnichannel & Digital
OPEN Health

View Agenda or Register